Kunos CA - Search Results

1

Triapine Radiochemotherapy in Advanced Stage Cervical Cancer.

Kunos CA, Ivy SP. Kunos CA, et al. Front Oncol. 2018 May 7;8:149. doi: 10.3389/fonc.2018.00149. eCollection 2018. Front Oncol. 2018. PMID: 29868473 Free PMC article.

2

Radiochemotherapy plus 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in advanced-stage cervical and vaginal cancers.

Kunos CA, Radivoyevitch T, Waggoner S, Debernardo R, Zanotti K, Resnick K, Fusco N, Adams R, Redline R, Faulhaber P, Dowlati A. Kunos CA, et al. Gynecol Oncol. 2013 Jul;130(1):75-80. doi: 10.1016/j.ygyno.2013.04.019. Epub 2013 Apr 18. Gynecol Oncol. 2013. PMID: 23603372 Free PMC article. Clinical Trial.

3

Long-Term Disease Control with Triapine-Based Radiochemotherapy for Patients with Stage IB2-IIIB Cervical Cancer.

Kunos CA, Sherertz TM. Kunos CA, et al. Front Oncol. 2014 Jul 24;4:184. doi: 10.3389/fonc.2014.00184. eCollection 2014. Front Oncol. 2014. PMID: 25105092 Free PMC article.

4

Phase I trial of daily triapine in combination with cisplatin chemotherapy for advanced-stage malignancies.

Kunos CA, Chu E, Beumer JH, Sznol M, Ivy SP. Kunos CA, et al. Cancer Chemother Pharmacol. 2017 Jan;79(1):201-207. doi: 10.1007/s00280-016-3200-x. Epub 2016 Nov 22. Cancer Chemother Pharmacol. 2017. PMID: 27878356 Free PMC article. Clinical Trial.

5

Commentary: Phase I Trial of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Ablative Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer.

Kunos CA. Kunos CA. Front Oncol. 2016 Dec 22;6:263. doi: 10.3389/fonc.2016.00263. eCollection 2016. Front Oncol. 2016. PMID: 28066719 Free PMC article. No abstract available.

6

Phase I Trial of Triapine-Cisplatin-Paclitaxel Chemotherapy for Advanced Stage or Metastatic Solid Tumor Cancers.

Kunos CA, Chu E, Makower D, Kaubisch A, Sznol M, Ivy SP. Kunos CA, et al. Front Oncol. 2017 Apr 4;7:62. doi: 10.3389/fonc.2017.00062. eCollection 2017. Front Oncol. 2017. PMID: 28421163 Free PMC article.

7

LC-MS/MS assay for the quantitation of the ribonucleotide reductase inhibitor triapine in human plasma.

Matsumoto J, Kiesel BF, Parise RA, Guo J, Taylor S, Huang M, Eiseman JL, Ivy SP, Kunos C, Chu E, Beumer JH. Matsumoto J, et al. J Pharm Biomed Anal. 2017 Nov 30;146:154-160. doi: 10.1016/j.jpba.2017.08.036. Epub 2017 Aug 31. J Pharm Biomed Anal. 2017. PMID: 28881312 Free PMC article.

8

Editorial: New Approaches to Radiation-Therapeutic Agent Cancer Care for Women.

Kunos CA, Kohn EC. Kunos CA, et al. Front Oncol. 2017 Nov 16;7:276. doi: 10.3389/fonc.2017.00276. eCollection 2017. Front Oncol. 2017. PMID: 29473016 Free PMC article. No abstract available.

9

Leveraging National Cancer Institute Programmatic Collaboration for Uterine Cervix Cancer Patient Accrual in Puerto Rico.

Kunos CA, Massett HA, Galassi A, Walker JL, Good MJ, Díaz LB, McCaskill-Stevens W. Kunos CA, et al. Front Oncol. 2018 Apr 10;8:102. doi: 10.3389/fonc.2018.00102. eCollection 2018. Front Oncol. 2018. PMID: 29692980 Free PMC article.

10

Radiopharmaceuticals for Relapsed or Refractory Leukemias.

Kunos CA, Capala J, Ivy SP. Kunos CA, et al. Front Oncol. 2019 Feb 25;9:97. doi: 10.3389/fonc.2019.00097. eCollection 2019. Front Oncol. 2019. PMID: 30859091 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters